SCHEMBL22019780

SCHEMBL22019780

CCc1c(CC(F)(F)F)nc2c(c1C)CCC2

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
GAA P10253 2/20 0.32
CYP1A2 P05177 1/20 0.32
KDM4E B2RXH2 5/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ACHE P22303 1/20 0.30
BPTF Q12830 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22020056 0.84 KMT2A (0.36) KMT2AMEN1MAPTTDP1GAA
SCHEMBL21963168 0.84 ACHE (0.43) KMT2AMEN1MAPTTDP1KDM4E
SCHEMBL22019991 0.80 KMT2A (0.33) KMT2AMEN1MAPTTDP1GAA
SCHEMBL22019989 0.79 KMT2A (0.34) KMT2AMEN1MAPTTDP1GAA
SCHEMBL22020719 0.78 SMN1; SMN2 (0.41) KMT2AMEN1MAPTTDP1GAA
SCHEMBL21963362 0.77 ACHE (0.46) KMT2AMEN1KDM4EMAPK1ALDH1A1
SCHEMBL24977994 0.72 SMN1; SMN2 (0.41) KMT2AMEN1MAPTTDP1GAA
SCHEMBL22019776 0.69 KDM4E (0.33) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL22020517 0.68 ACHE (0.48) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL22019990 0.67 NOS3 (0.46) KMT2AMEN1MAPTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed